Novel pharmacologic therapies for cystic fibrosis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Combining Gene Therapy with Current Modulator Treatments for Cystic Fibrosis: A Promising Area of Research.Pharmaceutics · 2026
   Review
2. Transcriptomic and Proteostasis Networks of CFTR and the Development of Small Molecule Modulators for the Treatment of Cystic Fibrosis Lung Disease.Genes · 2020
   Review
3. Interference with ubiquitination in CFTR modifies stability of core glycosylated and cell surface pools.Molecular and cellular biology · 2014
   Article
4. The iodide-transport-defect-causing mutation R124H: a δ-amino group at position 124 is critical for maturation and trafficking of the Na+/I- symporter.Journal of cell science · 2013
   Article
5. Applications of proteomic technologies for understanding the premature proteolysis of CFTR.Expert review of proteomics · 2010
   Review
6. Diagnosis of cystic fibrosis.Clinical reviews in allergy & immunology · 2008
   Review
7. Targeted therapy for cystic fibrosis: cystic fibrosis transmembrane conductance regulator mutation-specific pharmacologic strategies.Molecular diagnosis & therapy · 2006
   Review
8. Sildenafil (Viagra) corrects DeltaF508-CFTR location in nasal epithelial cells from patients with cystic fibrosis.Thorax · 2005
   Article
9. Atypical cystic fibrosis--diagnostic and management dilemmas.Journal of the Royal Society of Medicine · 2003
   Review
10. Recent advances in cystic fibrosis.Archives of disease in childhood · 2001
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as